01776nam 2200421Ia 450 991069661570332120080619115056.0(CKB)5470000002380708(OCoLC)232330615(EXLCZ)99547000000238070820080619d2008 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierDrug safety[electronic resource] preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /statement of Marcia Crosse[Washington, D.C.] :U.S. Govt. Accountability Office,[2008]19 pages digital, PDF fileTestimony ;GAO-08-701 TTitle from title screen (viewed on May 29, 2008)."For release ... April 22, 2008."Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.Includes bibliographical references.Drug safety DrugsSafety measuresDrugsInspectionDrugsSafety measures.DrugsInspection.Crosse Marcia1380679United States.Congress.House.Committee on Energy and Commerce.Subcommittee on Oversight and Investigations.United States.Government Accountability Office.GPOGPOBOOK9910696615703321Drug safety3449630UNINA